secwatch.observer — SEC 8-K summary
======================================

Issuer:     Simulations Plus, Inc. (SLP)
CIK:        0001023459
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001023459-23-000074
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Simulations Plus acquires Immunetrics for $15.5M+$8M earnout to expand QSP capabilities
--------------------------------------------------------------------------------

- Total consideration up to $23.5M: $15.5M cash at closing (incl. $1.8M holdback) plus up to $8M earnout based on 2023-2024 revenue.
- Acquisition closed June 16, 2023; Immunetrics becomes wholly-owned subsidiary of Simulations Plus.
- Expands QSP modeling into immunology/oncology; therapeutic areas covered increased by over 50% to 20.
- Steven Chang, ex-CEO of Immunetrics, appointed President of surviving entity with 2-year employment agreement; $330,000 base salary plus up to 10% bonus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023459/000102345923000074/0001023459-23-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023459/000102345923000074/slp-20230616.htm
  HTML page:      https://secwatch.observer/filing/0001023459-23-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer